With the closing date for handicap entries at the Cheltenham Festival fast approaching, Billy Nash takes a look at some of the Irish novices that have recently met the qualifying criteria.

Inventiva’s lanifibranor has been tipped to become a blockbuster in the fatty liver disease non-alcoholic steatohepatitis (NASH) after it became the first drug to hit two regulatory goals in a ...